MECHANISM OF APOLIPOPROTEIN B 100 THIOL DEPLETION DURING OXIDATION OF LDL
LDL 氧化过程中载脂蛋白 B 100 硫醇消耗的机制
基本信息
- 批准号:6307907
- 负责人:
- 金额:$ 1.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-03-01 至 2001-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Oxidation of low-density lipoprotein (LDL) is recognized to be a
key step in atherogenesis. Previous studies show that LDL contains
low molecular weight antioxidants such as vitamin E, beta-carotene,
and ubiquinol, that can retard oxidative modification. In this
report, we have evaluated the antioxidant potential of apolipoprotein
B-100 (apo-B) thiols during LDL oxidation. Both apo-B thiols and
vitamin E were depleted concomitantly during the lag phase of
Cu(2+)-mediated LDL oxidation. The rate of thiol depletion was
significantly inhibited by the lipophilic spin trap
N-tert-butyl-alpha-phenylnitrone (PBN) but not by the water-soluble
spin trap alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone (POBN).
Blocking apo-B thiols with sulfhydryl modifying agents increased the
oxidizability of LDL. As with Cu(2+), peroxynitrite also caused
depletion of apo-B thiols, and again thiol depletion was inhibited by
PBN but not by POBN. A PBN-lipid-derived radical adduct was observed
by the electron spin resonance (ESR) technique during oxidation of LDL
with peroxynitrite. We conclude that apo-B thiol depletion is
mediated by lipid peroxidation, prior to the onset of the propagation
phase of LDL oxidation. The implications of apo-B thiols as intrinsic
antioxidants of LDL are discussed.
低密度脂蛋白(LDL)的氧化被认为是一种
动脉粥样硬化形成的关键步骤。先前的研究表明,低密度脂蛋白含有
低分子抗氧化剂,如维生素E,β-胡萝卜素,
以及泛喹酚,它可以延缓氧化修饰。在这
据报道,我们已经评估了载脂蛋白的抗氧化潜力
低密度脂蛋白氧化过程中的B-100(apo-B)硫醇。载脂蛋白-B硫醇和
维生素E在营养不良的滞后期也随之耗尽。
Cu2+介导的低密度脂蛋白氧化。硫醇耗竭的速度是
被亲脂的自旋陷阱显著抑制
N-叔丁基-α-苯基硝酮(PBN),但不是由水溶性
自旋陷阱α-(4-吡啶-1-氧化物)-N-叔丁基硝酮(POBN)。
用巯基修饰剂封闭载脂蛋白-B硫醇可增加
低密度脂蛋白的氧化性。与铜(2+)一样,过亚硝酸根也会引起
抑制载脂蛋白B硫醇的消耗,又一次抑制硫醇的消耗。
PBN,而不是POBN。观察到一种PBN-脂质衍生的自由基加合物
用电子自旋共振(ESR)技术研究低密度脂蛋白氧化
用过亚硝酸根。我们得出结论,载脂蛋白B硫醇耗竭是
在繁殖开始之前,由脂质过氧化介导
低密度脂蛋白氧化阶段。载脂蛋白-B硫醇作为内源性的含义
讨论了低密度脂蛋白的抗氧化剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC FERGUSON其他文献
ERIC FERGUSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC FERGUSON', 18)}}的其他基金
POLYCLONARL ANTIBODY DIRECTED AGAINST HOMOCYSTEINE THIOLACTONE MODIFIEDLDL
针对高半胱氨酸硫内酯修饰LDL的多克隆抗体
- 批准号:
6307906 - 财政年份:2000
- 资助金额:
$ 1.13万 - 项目类别:
ANTIOXIDANT POTENTIAL OF HOMOCYSTAMIDE LDL ADDUCT
同型半酰胺低密度脂蛋白加合物的抗氧化潜力
- 批准号:
6307877 - 财政年份:2000
- 资助金额:
$ 1.13万 - 项目类别:
POLYCLONAL ANTIBODY DIRECTED AGAINST HOMOCYSTEINE THIOLACTONE MODIFIED LDL
针对同型半胱氨酸硫内酯修饰的 LDL 的多克隆抗体
- 批准号:
6118862 - 财政年份:1999
- 资助金额:
$ 1.13万 - 项目类别:
POLYCLONARL ANTIBODY DIRECTED AGAINST HOMOCYSTEINE THIOLACTONE MODIFIEDLDL
针对高半胱氨酸硫内酯修饰LDL的多克隆抗体
- 批准号:
6279881 - 财政年份:1998
- 资助金额:
$ 1.13万 - 项目类别:
MECHANISM OF APOLIPOPROTEIN B 100 THIOL DEPLETION DURING OXIDATION OF LDL
LDL 氧化过程中载脂蛋白 B 100 硫醇消耗的机制
- 批准号:
6279882 - 财政年份:1998
- 资助金额:
$ 1.13万 - 项目类别:
ANTIOXIDANT POTENTIAL OF HOMOCYSTAMIDE LDL ADDUCT
同型半酰胺低密度脂蛋白加合物的抗氧化潜力
- 批准号:
6279846 - 财政年份:1998
- 资助金额:
$ 1.13万 - 项目类别:
RADICAL MEDIATED APOLIPOPROTEIN B 100 THIOL DEPLETION
自由基介导的载脂蛋白 B 100 硫醇消耗
- 批准号:
6250044 - 财政年份:1997
- 资助金额:
$ 1.13万 - 项目类别:
HOMOCYSTEINE IN MODIFICATION OF LOW DENSITY LIPOPROTEIN
同型半胱氨酸修饰低密度脂蛋白
- 批准号:
6250043 - 财政年份:1997
- 资助金额:
$ 1.13万 - 项目类别:
APOLIPOPROTEIN B 100 THIOL DEPLETION DURING OXIDATION OF LDL
LDL 氧化过程中载脂蛋白 B 100 硫醇消耗
- 批准号:
5222143 - 财政年份:
- 资助金额:
$ 1.13万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 1.13万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 1.13万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 1.13万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 1.13万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 1.13万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 1.13万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 1.13万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 1.13万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 1.13万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 1.13万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)